New buy-film array panel - biofire-ddeamc

Ended Awarded Last action

Contract number
W91YTZ21F0148
Awardee
Awarding agency
Obligated
$291,521

Award facts

Opportunity
Contract value 100% obligated
$291,521.26 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Fort Gordon, GA 30905, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00006 · FY24 MOD RE-align FY23 funds 0011940268 (EAMC) -$57
Change Order P00005 · BCID2 panel,30 test-rfit-ASY-0147. FY21 deobligation. -$37,344
Funding Only Action P00004 · FY23 admin MOD eamc 0011940268 $109,641
Exercise an Option P00003 · FY23 OPT EXR eamc YR2 00119940268 $0
Exercise an Option P00002 · FY22 option year I W91YTZ21F0148 $109,641
Other Administrative Action P00001 · Administrative MOD to remove N/a clause $0
Original award $109,641

About this award

This federal contract award, valued at $291,521.26, was issued by the Defense Health Agency to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The contract provides for the delivery of new "FILM ARRAY PANEL - BIOFIRE-DDEAMC" products.

The contract was awarded against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. No set-aside designation was used. Biofire Diagnostics LLC has received numerous federal contract awards as a prime contractor, providing a variety of goods and services related to infectious disease testing, including molecular diagnostic testing, COVID-19 testing reagents and equipment, maintenance services, and supply of reagents and test kits. Major customers include the Department of Veterans Affairs, the Defense Health Agency, the Department of Health and Human Services Indian Health Service, and the Department of State. Biofire Diagnostics LLC also serves as a subcontractor on some federal contracts.

Quick answers

Who was awarded contract W91YTZ21F0148?

W91YTZ21F0148 was awarded to Biofire Diagnostics LLC by Medical Command (Department of the Army) on June 4, 2021.

How much is contract W91YTZ21F0148 worth?

The government has obligated $291,521 on W91YTZ21F0148.

Which agency awarded contract W91YTZ21F0148?

Medical Command (Department of the Army) awarded W91YTZ21F0148, with funding from Defense Health Agency (Department of Defense).

Is contract W91YTZ21F0148 an order under another contract?

Yes. W91YTZ21F0148 is a delivery order under V797D30085, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract W91YTZ21F0148 competed?

The extent of competition for W91YTZ21F0148 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award